United States ADHD Drugs Market Report 2017

Name: United States ADHD Drugs Market Report 2017
Brand: QYResearch
SKU: U9E2E2050E2EN
Price: 3800 USD
Availability: InStock

December 2017 | 101 pages | ID: U9E2E2050E2EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States ADHD Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of ADHD Drugs in these regions, from 2012 to 2022 (forecast).

United States ADHD Drugs market competition by top manufacturers/players, with ADHD Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Eli Lilly
Janssen Pharmaceuticals, Inc.
Shire
Perdue Pharma
Glaxosmith Kline
Novartis
Celltech Group
Johnson & Johnson

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Stimulants (Amphetamines, Methylphenidate)
Non-Stimulants
Antidepressants
Blood Pressure Medicines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Adults
Children

If you have any special requirements, please let us know and we will offer you the report as you want.

United States ADHD Drugs Market Report 2017

1 ADHD DRUGS OVERVIEW

1.1 Product Overview and Scope of ADHD Drugs
1.2 Classification of ADHD Drugs by Product Category
  1.2.1 United States ADHD Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States ADHD Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Stimulants (Amphetamines, Methylphenidate)
  1.2.4 Non-Stimulants
  1.2.5 Antidepressants
  1.2.6 Blood Pressure Medicines
1.3 United States ADHD Drugs Market by Application/End Users
  1.3.1 United States ADHD Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Adults
  1.3.3 Children
1.4 United States ADHD Drugs Market by Region
  1.4.1 United States ADHD Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West ADHD Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest ADHD Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic ADHD Drugs Status and Prospect (2012-2022)
  1.4.5 New England ADHD Drugs Status and Prospect (2012-2022)
  1.4.6 The South ADHD Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest ADHD Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of ADHD Drugs (2012-2022)
  1.5.1 United States ADHD Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States ADHD Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES ADHD DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States ADHD Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States ADHD Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States ADHD Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States ADHD Drugs Market Competitive Situation and Trends
  2.4.1 United States ADHD Drugs Market Concentration Rate
  2.4.2 United States ADHD Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers ADHD Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ADHD DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States ADHD Drugs Sales and Market Share by Region (2012-2017)
3.2 United States ADHD Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States ADHD Drugs Price by Region (2012-2017)

4 UNITED STATES ADHD DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States ADHD Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States ADHD Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States ADHD Drugs Price by Type (2012-2017)
4.4 United States ADHD Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ADHD DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States ADHD Drugs Sales and Market Share by Application (2012-2017)
5.2 United States ADHD Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ADHD DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Eli Lilly
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 ADHD Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Eli Lilly ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Janssen Pharmaceuticals, Inc.
  6.2.2 ADHD Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Janssen Pharmaceuticals, Inc. ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Shire
  6.3.2 ADHD Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Shire ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Perdue Pharma
  6.4.2 ADHD Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Perdue Pharma ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Glaxosmith Kline
  6.5.2 ADHD Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Glaxosmith Kline ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Novartis
  6.6.2 ADHD Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novartis ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Celltech Group
  6.7.2 ADHD Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Celltech Group ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Johnson & Johnson
  6.8.2 ADHD Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Johnson & Johnson ADHD Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 ADHD DRUGS MANUFACTURING COST ANALYSIS

7.1 ADHD Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of ADHD Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 ADHD Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of ADHD Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ADHD DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States ADHD Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States ADHD Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States ADHD Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States ADHD Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of ADHD Drugs
Figure United States ADHD Drugs Market Size (K Pcs) by Type (2012-2022)
Figure United States ADHD Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Stimulants (Amphetamines, Methylphenidate) Product Picture
Figure Non-Stimulants Product Picture
Figure Antidepressants Product Picture
Figure Blood Pressure Medicines Product Picture
Figure United States ADHD Drugs Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of ADHD Drugs by Application in 2016
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Children Examples
Table Key Downstream Customer in Children
Figure United States ADHD Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States ADHD Drugs Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States ADHD Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States ADHD Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States ADHD Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States ADHD Drugs Sales Share by Players/Suppliers
Figure 2017 United States ADHD Drugs Sales Share by Players/Suppliers
Figure United States ADHD Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States ADHD Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States ADHD Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States ADHD Drugs Revenue Share by Players/Suppliers
Figure 2017 United States ADHD Drugs Revenue Share by Players/Suppliers
Table United States Market ADHD Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market ADHD Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States ADHD Drugs Market Share of Top 3 Players/Suppliers
Figure United States ADHD Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers ADHD Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers ADHD Drugs Product Category
Table United States ADHD Drugs Sales (K Pcs) by Region (2012-2017)
Table United States ADHD Drugs Sales Share by Region (2012-2017)
Figure United States ADHD Drugs Sales Share by Region (2012-2017)
Figure United States ADHD Drugs Sales Market Share by Region in 2016
Table United States ADHD Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States ADHD Drugs Revenue Share by Region (2012-2017)
Figure United States ADHD Drugs Revenue Market Share by Region (2012-2017)
Figure United States ADHD Drugs Revenue Market Share by Region in 2016
Table United States ADHD Drugs Price (USD/Pcs) by Region (2012-2017)
Table United States ADHD Drugs Sales (K Pcs) by Type (2012-2017)
Table United States ADHD Drugs Sales Share by Type (2012-2017)
Figure United States ADHD Drugs Sales Share by Type (2012-2017)
Figure United States ADHD Drugs Sales Market Share by Type in 2016
Table United States ADHD Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States ADHD Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of ADHD Drugs by Type (2012-2017)
Figure Revenue Market Share of ADHD Drugs by Type in 2016
Table United States ADHD Drugs Price (USD/Pcs) by Types (2012-2017)
Figure United States ADHD Drugs Sales Growth Rate by Type (2012-2017)
Table United States ADHD Drugs Sales (K Pcs) by Application (2012-2017)
Table United States ADHD Drugs Sales Market Share by Application (2012-2017)
Figure United States ADHD Drugs Sales Market Share by Application (2012-2017)
Figure United States ADHD Drugs Sales Market Share by Application in 2016
Table United States ADHD Drugs Sales Growth Rate by Application (2012-2017)
Figure United States ADHD Drugs Sales Growth Rate by Application (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly ADHD Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly ADHD Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly ADHD Drugs Sales Market Share in United States (2012-2017)
Figure Eli Lilly ADHD Drugs Revenue Market Share in United States (2012-2017)
Table Janssen Pharmaceuticals, Inc. Basic Information List
Table Janssen Pharmaceuticals, Inc. ADHD Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Sales Growth Rate (2012-2017)
Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Sales Market Share in United States (2012-2017)
Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Revenue Market Share in United States (2012-2017)
Table Shire Basic Information List
Table Shire ADHD Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shire ADHD Drugs Sales Growth Rate (2012-2017)
Figure Shire ADHD Drugs Sales Market Share in United States (2012-2017)
Figure Shire ADHD Drugs Revenue Market Share in United States (2012-2017)
Table Perdue Pharma Basic Information List
Table Perdue Pharma ADHD Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Perdue Pharma ADHD Drugs Sales Growth Rate (2012-2017)
Figure Perdue Pharma ADHD Drugs Sales Market Share in United States (2012-2017)
Figure Perdue Pharma ADHD Drugs Revenue Market Share in United States (2012-2017)
Table Glaxosmith Kline Basic Information List
Table Glaxosmith Kline ADHD Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Glaxosmith Kline ADHD Drugs Sales Growth Rate (2012-2017)
Figure Glaxosmith Kline ADHD Drugs Sales Market Share in United States (2012-2017)
Figure Glaxosmith Kline ADHD Drugs Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis ADHD Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis ADHD Drugs Sales Growth Rate (2012-2017)
Figure Novartis ADHD Drugs Sales Market Share in United States (2012-2017)
Figure Novartis ADHD Drugs Revenue Market Share in United States (2012-2017)
Table Celltech Group Basic Information List
Table Celltech Group ADHD Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celltech Group ADHD Drugs Sales Growth Rate (2012-2017)
Figure Celltech Group ADHD Drugs Sales Market Share in United States (2012-2017)
Figure Celltech Group ADHD Drugs Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson ADHD Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson ADHD Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson ADHD Drugs Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson ADHD Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of ADHD Drugs
Figure Manufacturing Process Analysis of ADHD Drugs
Figure ADHD Drugs Industrial Chain Analysis
Table Raw Materials Sources of ADHD Drugs Major Players/Suppliers in 2016
Table Major Buyers of ADHD Drugs
Table Distributors/Traders List
Figure United States ADHD Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States ADHD Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States ADHD Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States ADHD Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States ADHD Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States ADHD Drugs Sales Volume (K Pcs) Forecast by Type in 2022
Table United States ADHD Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States ADHD Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States ADHD Drugs Sales Volume (K Pcs) Forecast by Application in 2022
Table United States ADHD Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States ADHD Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States ADHD Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States ADHD Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States ADHD Drugs Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports